Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Chimerix, Inc. (NASDAQ: CMRX).

Full DD Report for CMRX

You must become a subscriber to view this report.


Recent News from (NASDAQ: CMRX)

Recent Analysis Shows Camden Property Trust, Biglari, Argan, Chimerix, Workhorse Group, and Magellan Midstream Partners Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, May 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Camden Property Trust (NYSE:CPT), Biglari Holdings Inc. (NYSE:BH), Argan, ...
Source: GlobeNewswire
Date: May, 17 2018 08:20
Chimerix's (CMRX) CEO Michelle Berrey on Q1 2018 Results - Earnings Call Transcript
Chimerix Inc. (CMRX) Q1, 2018 Earning Conference Call May 7, 2018 8:30 AM ET Executives Michelle LaSpaluto – Senior Director-Accounting Michelle Berrey – President and Chief Executive Officer Garrett Nichols – Chief Medical Officer Linda Richardson –...
Source: SeekingAlpha
Date: May, 07 2018 14:41
Chimerix Inc 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Chimerix Inc in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 07 2018 14:29
Chimerix beats by $0.01, misses on revenue
Chimerix (NASDAQ: CMRX ): Q1 EPS of -$0.42 beats by $0.01 . More news on: Chimerix Inc, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 07 2018 07:01
Chimerix Announces First Quarter 2018 Financial Results
- Landmark AdVance Study Demonstrates Strong Correlation Between  Adenovirus Burden and Mortality Risk - - Site Initiations for AdAPT Study of Oral Short-course Brincidofovir for Adenovirus and IV Brincidofovir Programs Are Progressing – - First Presentation on CMX521...
Source: GlobeNewswire
Date: May, 07 2018 07:00
Chimerix to Present at the Deutsche Bank 43rd Annual Health Care Conference
DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that M. Michelle Berrey, M.D., M.P.H, President and Chief Executive Officer of Chimer...
Source: GlobeNewswire
Date: May, 02 2018 08:00
Chimerix to Announce First Quarter 2018 Financial Results on May 7, 2018
DURHAM, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it will host a live conference call and audio webcast on Monday, May 7, 2...
Source: GlobeNewswire
Date: April, 30 2018 08:00
Chimerix (CMRX) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
The following slide deck was published by Chimerix Inc in conjunction with this Read more ...
Source: SeekingAlpha
Date: April, 10 2018 12:17
Chimerix to Present at the H.C. Wainwright Annual Global Life Sciences Conference
DURHAM, N.C., April 02, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that Garrett Nichols, M.D., M.S., Chief Medical Officer of Chimerix will present at the ...
Source: GlobeNewswire
Date: April, 02 2018 08:00
Chimerix Announces Martha J. Demski as Board Chair; Appoints New Members to Board of Directors
DURHAM, N.C., March 29, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced the appointment of Martha J. Demski as Chair of the Board of Directors. Martha will succeed Ernest Mario, PhD...
Source: GlobeNewswire
Date: March, 29 2018 16:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-244.654.554.734.48118,360
2018-05-234.694.664.804.64323,476
2018-05-224.804.744.864.67122,049
2018-05-214.784.804.934.78252,631
2018-05-184.844.824.864.76157,814

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-244,85131,57115.3654Cover
2018-05-236,682129,5045.1597Cover
2018-05-229,91123,47142.2266Short
2018-05-2119,243118,26816.2707Cover
2018-05-1818,90886,67321.8153Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CMRX.


About Chimerix, Inc. (NASDAQ: CMRX)

Logo for Chimerix, Inc. (NASDAQ: CMRX)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: CMRX)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 07 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 07 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 26 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 26 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: April, 05 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 30 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 01 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: March, 01 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 01 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 14 2018

       

       


      Daily Technical Chart for (NASDAQ: CMRX)

      Daily Technical Chart for (NASDAQ: CMRX)


      Stay tuned for daily updates and more on (NASDAQ: CMRX)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: CMRX)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      Monsta Trader
      @MonstaTrader

       

       


      Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CMRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of CMRX and does not buy, sell, or trade any shares of CMRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/